The strong association between FTO SNPs or overweight/obesity with an increased risk of cancers suggests that the obesity‐associated function of FTO in metabolism may also contribute to its effects in cancers.49 This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.